Showing results (321-330 of 645) with videos related to
Sort By:
Pageof 65
Thrombosis and Haemostasis|October 1, 1995
Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in miceH R Lijnen, L Moons, V Beelen, et al.Thrombosis Research|May 15, 1991
Molecular forms of plasminogen activator inhibitor-1 (PAI-1) and tissue-type plasminogen activator (t-PA) in human plasmaM C Alessi, I Juhan-Vague, P J Declerck, et al.Thrombosis and Haemostasis|August 2, 1993
Functional properties of p-anisoylated plasmin-staphylokinase complexH R Lijnen, B Van Hoef, R A Smith, et al.FEBS Letters|August 19, 1999
Involvement of Sp1 in basal and retinoic acid induced transcription of the human tissue-type plasminogen activator geneP Merchiers, F Bulens, A De Vriese, et al.Thrombosis and Haemostasis|December 27, 1982
Kinetics of the inhibition of plasmin in acidified human plasmaH R Lijnen, M Maes, M Castel, et al.Blood|May 15, 1989
The mechanism of plasminogen activation and fibrin dissolution by single chain urokinase-type plasminogen activator in a plasma milieu in vitroH R Lijnen, B Van Hoef, F De Cock, et al.Atherosclerosis|December 2, 1999
Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in StockholmC Held, P Hjemdahl, N Håkan Wallén, et al.British Heart Journal|January 1, 1986
Haemostatic function in myocardial infarctionA Hamsten, M Blombäck, B Wiman, et al.European Heart Journal|May 6, 1998
Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic functionP Båvenholm, U de Faire, C Landou, et al.The Journal of Biological Chemistry|December 15, 1988
Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activatorH R Lijnen, L Nelles, B Van Hoef, et al.Pageof 65